Atlanta Georgia based BioCircuit Technologies is raising $9,000,000.00 in New Debt Financing.
Atlanta, GA – According to filings with the U.S. Securities and Exchange Commission, BioCircuit Technologies is raising $9,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Michelle Jarrard played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About BioCircuit Technologies
BioCircuit Technologies is a medical device company developing tools for neural interfacing and tissue repair. As a team of scientists, engineers, and programmers, BioCircuit is dedicated to the translation of cutting-edge neurotechnology research into powerful, yet practical, clinical tools. BioCircuits bioelectronic platform taps into nerve and muscle activity non-invasively, providing sensitive, high-resolution monitoring and selective, closed-loop stimulation. Useful in the fields of bioelectronic medicine, neuromodulation, neuroprosthetics, and neuromuscular rehabilitation, this technology provides clinicians with the ability to diagnose health conditions earlier, precisely deliver therapies and track outcomes over time, and reliably implement treatments tailored to individual patients. BioCircuits tissue repair portfolio includes Nerve Tape, an implantable mechanical device for the repair of injured nerves. Thanks to integrated microscale hooks, Nerve Tape wraps quickly and easily around severed nerve ends, forming a strong, reliable hold with distributed tension. Nerve Tape simplifies nerve repair, allowing surgeons to operate faster and achieve precise and reliable coaptation of injured peripheral nerves for improved recovery. BioCircuit is headquartered in Atlanta, GA and supported by the National Institutes of Health and healthcare technology investors.
To learn more about BioCircuit Technologies, visit http://www.biocircuit.com/
Contact:
Michelle Jarrard, Chief Executive Officer
404-433-9035
https://www.linkedin.com/in/michellejarrard/
SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved